Paper38414432
Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases.
Bolhuis DL and 2 others. Biochem Soc Trans, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases. Papers, record 38414432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38414432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ubiquitin-Protein Ligases | Major topic |
| Deubiquitinating Enzymes | Major topic |
| Ubiquitination | Major topic |
| Humans | |
| Animals | |
| Ubiquitin | |
| Autophagy | |
| Protein Processing, Post-Translational |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 GM120309 | NIGMS NIH HHS | United States | R01GM120309 | PubMed and NIH | NIH RePORTER |
| R35 GM128855 | NIGMS NIH HHS | United States | R35GM128855 | PubMed and NIH | NIH RePORTER |
| T32 GM008570 | NIGMS NIH HHS | United States | T32GM008570 | PubMed and NIH | NIH RePORTER |
References445
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23758787 | TRAF molecules in cell signaling and in human diseases. | J Mol Signal | 2013 | https://conductscience.org/library/papers/23758787 | PubMed |
| 2 | 25547493 | USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25547493 | PubMed |
| 3 | 15334086 | The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. | Nat Immunol | 2004 | https://conductscience.org/library/papers/15334086 | PubMed |
| 4 | 31056254 | Ubiquitin-specific protease 3 targets TRAF6 for deubiquitination and suppresses IL-1β induced chondrocyte apoptosis. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31056254 | PubMed |
| 5 | 26169834 | Deubiquitinase USP47/UBP64E Regulates β-Catenin Ubiquitination and Degradation and Plays a Positive Role in Wnt Signaling. | Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26169834 | PubMed |
| 6 | 29326710 | Ubiquitin-Specific Protease 14 Negatively Regulates Toll-Like Receptor 4-Mediated Signaling and Autophagy Induction by Inhibiting Ubiquitination of TAK1-Binding Protein 2 and Beclin 1. | Front Immunol | 2017 | https://conductscience.org/library/papers/29326710 | PubMed |
| 7 | 31044085 | USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia. | Cell Discov | 2019 | https://conductscience.org/library/papers/31044085 | PubMed |
| 8 | 35022505 | Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer. | Lab Invest | 2022 | https://conductscience.org/library/papers/35022505 | PubMed |
| 9 | 24777531 | USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. | Nat Immunol | 2014 | https://conductscience.org/library/papers/24777531 | PubMed |
| 10 | 36976509 | The Interaction of OTUB1 and TRAF3 Mediates NLRP3 Inflammasome Activity to Regulate TGF-β1-induced BEAS-2B Cell Injury. | Appl Biochem Biotechnol | 2023 | https://conductscience.org/library/papers/36976509 | PubMed |
| 11 | 21247385 | SCF E3 ubiquitin ligases as anticancer targets. | Curr Cancer Drug Targets | 2011 | https://conductscience.org/library/papers/21247385 | PubMed |
| 12 | 17038327 | The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. | J Biol Chem | 2006 | https://conductscience.org/library/papers/17038327 | PubMed |
| 13 | 18977328 | Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18977328 | PubMed |
| 14 | 25403879 | Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. | Cell Mol Life Sci | 2015 | https://conductscience.org/library/papers/25403879 | PubMed |
| 15 | 37202390 | FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37202390 | PubMed |
| 16 | 29018447 | TRIM25 in the Regulation of the Antiviral Innate Immunity. | Front Immunol | 2017 | https://conductscience.org/library/papers/29018447 | PubMed |
| 17 | 32683298 | Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32683298 | PubMed |
| 18 | 20940148 | The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/20940148 | PubMed |
| 19 | 25716680 | Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. | Cancer Res | 2015 | https://conductscience.org/library/papers/25716680 | PubMed |
| 20 | 18952891 | HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. | Blood | 2009 | https://conductscience.org/library/papers/18952891 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881390 | It takes two to tango: the intersection of deubiquitinases and m6A modification in cancer. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42881390 | PubMed |
| 42817983 | Substrate Profiling of RNF216 Uncovers a Translation-Linked OTUD4 Regulatory Axis. | bioRxiv | 2026 | https://conductscience.org/library/papers/42817983 | PubMed |
| 42494871 | Ubiquitination modifications as central regulators of metabolic dysfunction in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42494871 | PubMed |
| 42302908 | Proteome-wide Ubiquitinome Profiling Reveals Substrate-specific Dynamics Within the USP7 Network. | Mol Cell Proteomics | 2026 | https://conductscience.org/library/papers/42302908 | PubMed |
| 41637663 | Cardiomyocyte-Derived USP20 Attenuates Diabetic Cardiomyopathy by Facilitating the Degradation of STING and Mitigating STING-Mediated Inflammation. | FASEB J | 2026 | https://conductscience.org/library/papers/41637663 | PubMed |
| 40703447 | The ubiquitin code of RAS proteins: Decoding its role in cancer progression. | iScience | 2025 | https://conductscience.org/library/papers/40703447 | PubMed |
| 40379725 | USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination. | Nat Commun | 2025 | https://conductscience.org/library/papers/40379725 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38414432
GET https://conductscience.org/api/papers/v1/38414432/references?page=2